Stephen M. Schwartz

Papers

Total Citations

H-Index

About

Stephen M. Schwartz is a leading epidemiologist and public health researcher whose work has profoundly shaped our understanding of cancer etiology, prevention, and treatment outcomes. His key research areas span cancer epidemiology, molecular epidemiology, and comparative effectiveness research, with a particular focus on head and neck cancers, including oropharyngeal squamous cell carcinoma (OPSCC). Schwartz’s major contributions include landmark studies evaluating the long-term functional outcomes of different treatment modalities for OPSCC. His highly cited 2016 paper, "Survival and Gastrostomy Prevalence in Patients With Oropharyngeal Cancer Treated With Transoral Robotic Surgery vs Chemoradiotherapy" (68 citations), provided critical evidence comparing the morbidity of transoral robotic surgery (TORS) versus chemoradiotherapy, directly informing clinical decision-making for patients and oncologists. Beyond this work, Schwartz has published extensively on the molecular epidemiology of cancer, investigating how genetic and environmental factors interact to influence cancer risk. His research has been instrumental in advancing precision medicine approaches and improving quality of life for cancer survivors. With a career spanning decades, Schwartz’s work continues to be widely cited and has helped bridge the gap between epidemiological research and clinical practice, making him a respected authority in cancer epidemiology and treatment outcomes research.